Sarah Potez’s Post

How do you purify small volumes for preclinical and clinical studies without losing too much to processing or leaving capacity unused? The newest member of the ÄKTA ready platform: ÄKTA ready 450 system Get a demo now! >> https://cytiva.link/njg3d #genetherapy #viralvectors #viralvectorpurification

How do you purify small volumes for preclinical and clinical studies without losing too much to processing or leaving capacity unused? The newest member of the ÄKTA ready platform: ÄKTA ready 450 system Get a demo now! >> https://cytiva.link/njg3d #genetherapy #viralvectors #viralvectorpurification

How do you purify small volumes for preclinical and clinical studies without losing too much to processing or leaving capacity unused? The newest member of the ÄKTA ready platform: ÄKTA ready 450 system Get a demo now! >> https://cytiva.link/njg3d #genetherapy #viralvectors #viralvectorpurification

How do you purify small volumes for preclinical and clinical studies without losing too much to processing or leaving capacity unused? The newest member of the ÄKTA ready platform: ÄKTA ready 450 system Get a demo now! >> https://cytiva.link/njg3d #genetherapy #viralvectors #viralvectorpurification

How do you purify small volumes for preclinical and clinical studies without losing too much to processing or leaving capacity unused? The newest member of the ÄKTA ready platform: ÄKTA ready 450 system Get a demo now! >> https://cytiva.link/njg3d #genetherapy #viralvectors #viralvectorpurification

How do you purify small volumes for preclinical and clinical studies without losing too much to processing or leaving capacity unused? The newest member of the ÄKTA ready platform: ÄKTA ready 450 system Get a demo now! >> https://cytiva.link/njg3d #genetherapy #viralvectors #viralvectorpurification

How do you purify small volumes for preclinical and clinical studies without losing too much to processing or leaving capacity unused? The newest member of the ÄKTA ready platform: ÄKTA ready 450 system Get a demo now! >> https://cytiva.link/njg3d #genetherapy #viralvectors #viralvectorpurification

How do you purify small volumes for preclinical and clinical studies without losing too much to processing or leaving capacity unused? The newest member of the ÄKTA ready platform: ÄKTA ready 450 system Get a demo now! >> https://cytiva.link/njg3d #genetherapy #viralvectors #viralvectorpurification

How do you purify small volumes for preclinical and clinical studies without losing too much to processing or leaving capacity unused? The newest member of the ÄKTA ready platform: ÄKTA ready 450 system Get a demo now! >> https://cytiva.link/njg3d #genetherapy #viralvectors #viralvectorpurification

Scrip features Form Bio CEO **What Does 2024 Hold For Biopharma? Part 4: Transformative Technology** The Rise And Rise Of Artificial Intelligence “Whereas 2023 was a year of progress for AI-enabled drug discovery, it’s important to look beyond the discovery stage to the equally complex and data-rich preclinical development stage,” said Kent Wakeford, co-CEO of Form Bio. “We can expect to see biopharma companies taking their 2023 learnings from early pursuits in AI drug discovery – and applying those lessons and new capabilities to their downstream efforts. 2024 will usher in the systematic integration of in silico task-based AI insights and bench science to enable biopharma companies to rapidly address efficacy, safety and manufacturability – to more rapidly advance therapeutics from discovery to the clinic.” Full article here: https://hubs.li/Q02jcPdl0 #insilico #AI #drugdiscovery #biopharma #genetherapy